Hans H Wandall
Co-Founder at Hemab Therapeutics
Hans H Wandall is a Co-Founder at Hemab Therapeutics, based in Copenhagen, Capital, Denmark.
In their own words: "Professor, MD, PhD".
Hemab Therapeutics: Pioneering therapies for bleeding disorders that medicine left behind.
Hemab Therapeutics's latest round on file is a Series C.
Adamlead doesn't have Hans's email yet; it's added when we find and verify it.
- Work email
- Not on file yet
- Company
Hemab Therapeuticshemab.com
More people at Hemab Therapeutics
- Angela VolkertVice President, Clinical ResearchVerified
- Associate DirectorClinical OperationsUnverified
- Benny SorensenChief Executive OfficerVerified
- Bernd SchadenDirector, Supply Chain, CMCVerified
- Christina GrosseOffice/HR Manager and Executive Assistant to the Head of CMC & ManufacturingVerified
- Erik BjornsonVice President, Regulatory AffairsVerified
- Jennifer DupeeExecutive Assistant/Office ManagerUnverified
- Joe VogelSenior Director, Program LeadershipVerified
- Karen WeisbachChief People and Culture OfficerVerified
- Kathryn ZwetchkenbaumManager, Human Resources and Executive AssistantVerified
- Leyna ChoSenior Clinical Trial AssociateVerified
- Lisa JohnsenAssociate Director, Medical WritingVerified
28 people on file at Hemab Therapeutics.
Is this you? Ask for your details to be removed.